...Current Research at Weill CornellToggle Current Research at Weill Cornell menu options Building and Benefiting...
https://endoflife.weill.cornell.edu/research
...TRILOGY ACS: Prasugrel of benefit only after angiography?...
http://vivo.med.cornell.edu/individuallist?page=83&vclassId=http%3A%2F%2Fweill.cornell.edu%2Fvivo%2Fontology%2Fwcmc%23Comment
...The Weill Department of Medicine menu options WDOM Well-Being Committee Notable Alumni Salary and Benefits...
https://medicine.weill.cornell.edu/divisions-programs/gastroenterology-hepatology/education/fellowships/inflammatory-bowel-disease-ibd
...Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from...
https://eipm.weill.cornell.edu/publications?page=9&s=type&o=desc
...Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from...
https://eipm.weill.cornell.edu/publications?page=9&s=title&o=desc
...Consistent survival benefit of enzalutamide plus androgen deprivation therapy in men with nonmetastatic...
https://eipm.weill.cornell.edu/publications?page=8&s=author&o=asc
...Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from...
https://eipm.weill.cornell.edu/publications?page=33&s=author&o=desc
...Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.....
https://eipm.weill.cornell.edu/publications?page=33&s=author&o=asc
...Consistent survival benefit of enzalutamide plus androgen deprivation therapy in men with nonmetastatic...
https://eipm.weill.cornell.edu/publications?page=28&s=author&o=desc
...Putative Biomarkers of Clinical Benefit With Pembrolizumab in Advanced Urothelial Cancer: Results from...
https://eipm.weill.cornell.edu/publications?page=27&s=type&o=asc
